Skip to main content
logo
Telix Pharmaceuticals Limited (ASX:TLX)
Australia flag Australia · Delayed Price · Currency is AUD
17.64
-0.56 (-3.08%)
Aug 8, 2025, 4:18 PM AEST

Satixfy Communications Revenue

In the year 2024, Telix Pharmaceuticals had annual revenue of 783.21M AUD with 55.85% growth. Telix Pharmaceuticals had revenue of 209.62M in the quarter ending December 31, 2024, with 48.82% growth.

Revenue
783.21M
Revenue Growth
+55.85%
P/S Ratio
7.62
Revenue / Employee
1.85M
Employees
234
Market Cap
5.97B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024783.21M280.66M55.85%
Dec 31, 2023502.55M342.45M213.90%
Dec 31, 2022160.10M152.50M2,007.64%
Dec 31, 20217.60M2.38M45.71%
Dec 31, 20205.21M1.73M49.58%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
CSL Limited24.61B
Pro Medicus184.58M
Cochlear2.31B
Sonic Healthcare9.33B
Ramsay Health Care17.12B
Ansell3.00B
Mesoblast9.16M
Regis Healthcare1.10B
Revenue Rankings

Telix Pharmaceuticals News

More News